Why the study?
Does intra-arterial fasudil improve increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure?
Does intra-arterial fasudil improve increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure?
Intra-arterial infusion of the Rho-kinase inhibitor fasudil improves increased forearm vascular resistance and impaired vasodilation in patients with heart failure, suggesting Rho-kinase involvement in peripheral circulation abnormalities.
Answers are grounded in this paper and cite their sources.
Supports Rho-kinase contribution to HF vascular resistance; leaves open therapeutic potential of inhibition.
BACKGROUND: Rho-kinase is suggested to have an important role in enhanced vasoconstriction in animal models of heart failure (HF). Patients with HF are characterized by increased vasoconstriction and reduced vasodilator responses to reactive hyperemia and exercise. The aim of the present study was to examine whether Rho-kinase is involved in the peripheral circulation abnormalities of HF in humans with the Rho-kinase inhibitor fasudil. METHODS AND RESULTS: Studies were performed in patients with HF (HF group, n=26) and an age-matched control group (n=26). Forearm blood flow was measured with a strain-gauge plethysmograph during intra-arterial infusion of graded doses of fasudil or sodium nitroprusside. Resting forearm vascular resistance (FVR) was significantly higher in the HF group than in the control group. The increase in forearm blood flow evoked by fasudil was significantly greater in the HF group than in the control group. The increased FVR was decreased by fasudil in the HF group toward the level of the control group. By contrast, FVR evoked by sodium nitroprusside was comparable between the 2 groups. Fasudil significantly augmented the impaired ischemic vasodilation during reactive hyperemia after arterial occlusion of the forearm in the HF group but not in the control group. Fasudil did not augment the increased FVR evoked by phenylephrine in the control group significantly. CONCLUSIONS: These results indicate that Rho-kinase is involved in increased FVR and impaired vasodilation of the forearm in patients with HF.
No takes yet. Share an insight, caveat, or question.
Kishi et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: